Cargando…

Image-Guided Cancer Nanomedicine

Multifunctional nanoparticles with superior imaging properties and therapeutic effects have been extensively developed for the nanomedicine. However, tumor-intrinsic barriers and tumor heterogeneity have resulted in low in vivo therapeutic efficacy. The poor in vivo targeting efficiency in passive a...

Descripción completa

Detalles Bibliográficos
Autor principal: Kim, Dong-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197060/
https://www.ncbi.nlm.nih.gov/pubmed/30364459
http://dx.doi.org/10.3390/jimaging4010018
_version_ 1783364681340026880
author Kim, Dong-Hyun
author_facet Kim, Dong-Hyun
author_sort Kim, Dong-Hyun
collection PubMed
description Multifunctional nanoparticles with superior imaging properties and therapeutic effects have been extensively developed for the nanomedicine. However, tumor-intrinsic barriers and tumor heterogeneity have resulted in low in vivo therapeutic efficacy. The poor in vivo targeting efficiency in passive and active targeting of nanotherapeutics along with the toxicity of nanoparticles has been a major problem in nanomedicine. Recently, image-guided nanomedicine, which can deliver nanoparticles locally using non-invasive imaging and interventional oncology techniques, has been paid attention as a new opportunity of nanomedicine. This short review will discuss the existing challenges in nanomedicine and describe the prospects for future image-guided nanomedicine.
format Online
Article
Text
id pubmed-6197060
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-61970602018-10-22 Image-Guided Cancer Nanomedicine Kim, Dong-Hyun J Imaging Article Multifunctional nanoparticles with superior imaging properties and therapeutic effects have been extensively developed for the nanomedicine. However, tumor-intrinsic barriers and tumor heterogeneity have resulted in low in vivo therapeutic efficacy. The poor in vivo targeting efficiency in passive and active targeting of nanotherapeutics along with the toxicity of nanoparticles has been a major problem in nanomedicine. Recently, image-guided nanomedicine, which can deliver nanoparticles locally using non-invasive imaging and interventional oncology techniques, has been paid attention as a new opportunity of nanomedicine. This short review will discuss the existing challenges in nanomedicine and describe the prospects for future image-guided nanomedicine. 2018-01-11 2018 /pmc/articles/PMC6197060/ /pubmed/30364459 http://dx.doi.org/10.3390/jimaging4010018 Text en http://creativecommons.org/licenses/by/4.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kim, Dong-Hyun
Image-Guided Cancer Nanomedicine
title Image-Guided Cancer Nanomedicine
title_full Image-Guided Cancer Nanomedicine
title_fullStr Image-Guided Cancer Nanomedicine
title_full_unstemmed Image-Guided Cancer Nanomedicine
title_short Image-Guided Cancer Nanomedicine
title_sort image-guided cancer nanomedicine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197060/
https://www.ncbi.nlm.nih.gov/pubmed/30364459
http://dx.doi.org/10.3390/jimaging4010018
work_keys_str_mv AT kimdonghyun imageguidedcancernanomedicine